https://koreaequitylens.com/about-korea-equity-lens/ 2026-08-21T05:19:17+00:00 https://koreaequitylens.com/about-korea-equity-lens-privacy-policy/ 2026-08-21T05:23:26+00:00 https://koreaequitylens.com/research-ligachem-biosciences-141080-im-securities-clinical-data-%c2%b7-pipeline-progress-%c2%b7-tech-transfer-2026-05-21/ 2026-08-21T06:38:01+00:00 https://koreaequitylens.com/research-ligachem-biosciences-141080-kyobo-securities-pipeline-clinical-progress-%c2%b7-ind-filings-%c2%b7-tech-transfer-2026-04-01/ 2026-08-21T06:41:08+00:00 https://koreaequitylens.com/research-ligachem-biosciences-141080-shinhan-securities-conjuall-%c2%b7-clinical-milestones-%c2%b7-big-pharma-l-o-2026-03-24/ 2026-08-21T06:42:50+00:00 https://koreaequitylens.com/research-ligachem-biosciences-141080-mirae-asset-securities-clinical-readouts-%c2%b7-pipeline-valuation-%c2%b7-sotp-2026-01-26/ 2026-08-21T06:51:55+00:00 https://koreaequitylens.com/research-ligachem-biosciences-141080-ibk-securities-enhertu-resistance-%c2%b7-clinical-readouts-%c2%b7-tech-transfer-2025-11-27/ 2026-08-21T06:54:17+00:00 https://koreaequitylens.com/research-ligachem-biosciences-141080-im-securities-platform-valuation-%c2%b7-pipeline-milestones-%c2%b7-deal-expansion-2025-08-12/ 2026-08-21T06:55:48+00:00 https://koreaequitylens.com/research-ligachem-biosciences-141080-mirae-asset-securities-clinical-milestones-%c2%b7-commercialization-potential-%c2%b7-platform-poc-2025-05-23/ 2026-08-21T06:57:35+00:00 https://koreaequitylens.com/research-ligachem-biosciences-141080-yuanta-securities-payload-chemistry-%c2%b7-safety-profile-%c2%b7-differentiation-2025-05-22/ 2026-08-21T06:59:32+00:00 https://koreaequitylens.com/research-ligachem-biosciences-141080-eugene-investment-securities-pipeline-clinical-progression-%c2%b7-licensing-revenue-%c2%b7-earnings-turnaround-2025-02-17/ 2026-08-21T07:01:24+00:00 https://koreaequitylens.com/research-abl-bio-298380-kyobo-securities-abl001-clinical-data-%c2%b7-market-overreaction-%c2%b7-grabody-b-potential-2026-04-29/ 2026-08-21T07:09:18+00:00 https://koreaequitylens.com/research-abl-bio-298380-ds-investment-securities-abl001-data-failure-%c2%b7-grabody-platforms-%c2%b7-intrinsic-value-2026-04-28/ 2026-08-21T07:11:17+00:00 https://koreaequitylens.com/research-abl-bio-298380-ds-investment-securities-abl001-data-readout-%c2%b7-abl111-phase-3-%c2%b7-grabody-b-expansion-2026-04-07/ 2026-08-21T07:20:53+00:00 https://koreaequitylens.com/research-abl-bio-298380-mirae-asset-securities-bbb-shuttle-re-rating-%c2%b7-igf1r-competitiveness-%c2%b7-abl001-data-readout-2026-03-26/ 2026-08-21T07:22:27+00:00 https://koreaequitylens.com/research-abl-bio-298380-ds-investment-securities-sanofi-strategy-%c2%b7-grabody-b-validity-%c2%b7-muscle-shuttle-expansion-2026-02-02/ 2026-08-21T07:37:47+00:00 https://koreaequitylens.com/research-abl-bio-298380-shinhan-securities-sanofi-strategy-%c2%b7-clinical-differentiation-%c2%b7-platform-expansion-2026-02-02/ 2026-08-21T07:39:10+00:00 https://koreaequitylens.com/research-abl-bio-298380-kiwoom-securities-abl301-deprioritization-%c2%b7-abl001-valuation-%c2%b7-grabody-b-validity-2026-02-02/ 2026-08-21T07:58:12+00:00 https://koreaequitylens.com/research-abl-bio-298380-yuanta-securities-givastomig-efficacy-%c2%b7-bispecific-adc-%c2%b7-platform-valuation-2026-01-29/ 2026-08-21T08:16:44+00:00 https://koreaequitylens.com/research-lig-da-079550-daishin-securities-2q26-review-%c2%b7-backlog-realization-%c2%b7-export-margin-expansion-2026-08-10/ 2026-08-21T08:30:38+00:00 https://koreaequitylens.com/research-lig-da-079550-sk-securities-capex-expansion-%c2%b7-global-interceptor-shortage-%c2%b7-earnings-quality-2026-08-10/ 2026-08-21T08:33:30+00:00 https://koreaequitylens.com/research-lig-da-079550-ds-investment-securities-order-expansion-%c2%b7-iraq-cheongung-ii-mass-production-%c2%b7-long-term-earnings-growth-2026-08-07/ 2026-08-21T08:42:00+00:00 https://koreaequitylens.com/research-lig-da-079550-yuanta-securities-cheongung-ii-demand-surge-%c2%b7-opm-guidance-upgrade-%c2%b7-middle-east-overlap-2026-08-07/ 2026-08-21T08:45:12+00:00 https://koreaequitylens.com/research-lig-da-079550-eugene-investment-securities-global-demand-spillover-%c2%b7-capex-expansion-%c2%b7-long-term-compounding-2026-08-07/ 2026-08-21T08:48:19+00:00 https://koreaequitylens.com/research-lig-da-079550-shinhan-securities-structural-export-growth-%c2%b7-order-pipeline-%c2%b7-long-term-demand-2026-08-07/ 2026-08-21T08:51:58+00:00 https://koreaequitylens.com/research-lig-da-079550-im-securities-export-pipeline-%c2%b7-capex-hiring-expansion-%c2%b7-global-air-defense-growth-2026-08-07/ 2026-08-21T08:56:50+00:00 https://koreaequitylens.com/research-lig-da-079550-kiwoom-securities-order-visibility-%c2%b7-production-expansion-%c2%b7-middle-east-deliveries-2026-08-07/ 2026-08-21T08:58:36+00:00 https://koreaequitylens.com/research-lig-da-079550-kiwoom-securities-k-defense-competitiveness-%c2%b7-pipeline-expansion-%c2%b7-rheinmetall-jv-2026-06-17/ 2026-08-21T09:24:25+00:00 https://koreaequitylens.com/research-lig-da-079550-daishin-securities-1q26-review-%c2%b7-earnings-surprise-%c2%b7-export-diversification-2026-05-08/ 2026-08-21T09:56:21+00:00 https://koreaequitylens.com/research-lig-da-079550-hana-securities-1q26-earnings-beat-%c2%b7-backlog-re-rating-%c2%b7-high-margin-follow-on-services-2026-05-08/ 2026-08-21T09:59:03+00:00 https://koreaequitylens.com/research-lig-da-079550-eugene-investment-securities-non-cheongung-potential-%c2%b7-high-margin-legacy-defense-%c2%b7-earnings-surprise-2026-05-08/ 2026-08-21T10:02:19+00:00 https://koreaequitylens.com/research-lig-da-079550-ks-sk-securities-1q26-earnings-beat-%c2%b7-overdone-correction-%c2%b7-global-demand-expansion-2026-05-08/ 2026-08-21T10:06:01+00:00 https://koreaequitylens.com/research-lig-da-079550-shinhan-securities-1q26-surprise-%c2%b7-demand-surge-%c2%b7-long-term-compounding-2026-05-08/ 2026-08-21T10:08:50+00:00 https://koreaequitylens.com/research-lig-da-079550-im-securities-premier-air-defense-scarcity-%c2%b7-target-price-upgrade-%c2%b7-global-inquiries-2026-05-08/ 2026-08-21T10:16:58+00:00 https://koreaequitylens.com/research-lig-da-079550-kiwoom-securities-expanding-order-opportunities-%c2%b7-1q26-earnings-beat-%c2%b7-global-air-defense-growth-2026-05-08/ 2026-08-21T10:19:08+00:00 https://koreaequitylens.com/research-lig-da-079550-kiwoom-securities-supply-shortage-vs-rising-demand-%c2%b7-middle-east-backlog-%c2%b7-haegung-expansion-2026-04-30/ 2026-08-21T10:21:01+00:00 https://koreaequitylens.com/research-lig-da-079550-sk-securities-modern-warfare-leader-%c2%b7-limited-global-capex-%c2%b7-multiple-re-rating-2026-04-07/ 2026-08-21T10:23:07+00:00 https://koreaequitylens.com/research-lig-da-079550-hana-securities-complementing-patriot-%c2%b7-cheongung-ii-cost-competitiveness-%c2%b7-krw-26-2t-backlog-2026-03-03/ 2026-08-21T10:31:50+00:00 https://koreaequitylens.com/research-lig-da-079550-hanwha-investment-securities-4q25-review-%c2%b7-ghost-robotics-impairment-cleared-%c2%b7-margin-expansion-2026-02-23/ 2026-08-21T10:39:13+00:00 https://koreaequitylens.com/research-lig-da-079550-shinhan-securities-4q25-one-off-shock-%c2%b7-krw-26-2t-backlog-%c2%b7-long-term-structural-growth-2026-02-20/ 2026-08-21T10:41:37+00:00 https://koreaequitylens.com/research-lig-da-079550-hana-securities-4q25-miss-%c2%b7-solid-order-backlog-%c2%b7-medium-to-long-term-fundamentals-2026-02-19/ 2026-08-21T10:43:28+00:00 https://koreaequitylens.com/research-lig-da-079550-yuanta-securities-4q25-review-%c2%b7-conservative-2026e-guidance-%c2%b7-long-term-structural-growth-2026-02-19/ 2026-08-21T10:46:24+00:00 https://koreaequitylens.com/research-lig-da-079550-kiwoom-securities-defense-export-expansion-%c2%b7-gr-turnaround-%c2%b7-2026e-upward-2026-02-19/ 2026-08-21T10:49:03+00:00 https://koreaequitylens.com/research-lig-da-079550-hanwha-investment-securities-3q25-review-%c2%b7-secured-growth-materialization-%c2%b7-expanding-export-share-2025-11-07/ 2026-08-21T10:52:32+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-mirae-asset-north-american-ess-%c2%b7-european-lfp-orders-%c2%b7-market-share-expansion-2026-08-13/ 2026-08-21T11:05:05+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-hana-securities-north-america-jv-resolution-%c2%b7-ess-line-conversion-%c2%b7-earnings-estimate-upgrades-2026-08-12/ 2026-08-21T11:10:36+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-ds-investment-securities-core-profitability-turnaround-%c2%b7-robust-ess-backlog-%c2%b7-humanoid-physical-ai-expansion-2026-07-31/ 2026-08-21T11:13:36+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-hana-securities-turnaround-to-profit-%c2%b7-north-america-ess-ramp-up-%c2%b7-valuation-upside-2026-07-31/ 2026-08-21T11:19:26+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-daishin-securities-earlier-turnaround-%c2%b7-north-america-ess-expansion-%c2%b7-lfp-order-pipeline-2026-07-31/ 2026-08-21T11:21:05+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-mirae-asset-operating-profit-upgrades-%c2%b7-core-turnaround-%c2%b7-prismatic-competitiveness-2026-07-31/ 2026-08-21T11:23:58+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-ibk-securities-ess-shipment-expansion-%c2%b7-ampc-benefits-%c2%b7-profit-turnaround-2026-07-31/ 2026-08-22T04:31:03+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-shinhan-securities-ess-bbu-growth-%c2%b7-profit-turnaround-%c2%b7-core-earnings-sustainability-2026-07-31/ 2026-08-22T04:38:01+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-kiwoom-securities-quarterly-turnaround-%c2%b7-ess-lfp-ramp-up-%c2%b7-europe-ev-market-share-2026-07-31/ 2026-08-22T05:15:15+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-im-securities-ess-business-pivot-%c2%b7-ampc-benefits-%c2%b7-earnings-visibility-2026-07-31/ 2026-08-22T05:19:41+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-shinhan-securities-profit-turnaround-%c2%b7-ess-margin-support-%c2%b7-north-america-lfp-ramp-up-2026-07-20/ 2026-08-22T05:56:41+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-im-securities-aidc-ess-demand-%c2%b7-us-regulation-benefits-%c2%b7-profit-turnaround-2026-06-30/ 2026-08-22T05:58:46+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-mirae-asset-securities-data-center-ess-%c2%b7-potential-sdc-monetization-%c2%b7-operating-profit-turnaround-2026-06-26/ 2026-08-22T06:03:55+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-im-securities-aidc-ess-demand-%c2%b7-us-regulation-benefits-%c2%b7-medium-to-long-term-growth-2026-05-11/ 2026-08-22T06:10:43+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-sk-securities-plant-utilization-recovery-%c2%b7-north-america-ess-expansion-%c2%b7-ampc-benefits-2026-04-29/ 2026-08-22T06:12:52+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-kyobo-securities-ai-data-center-bbu-%c2%b7-direct-csp-channels-%c2%b7-1q-earnings-beat-2026-04-29/ 2026-08-22T06:15:13+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-hanwha-investment-securities-sequential-segment-recovery-%c2%b7-order-pipeline-visibility-%c2%b7-form-factor-diversification-2026-04-29/ 2026-08-22T06:17:07+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-ds-investment-securities-4q-turnaround-visibility-%c2%b7-non-pfe-lfp-ess-%c2%b7-european-volume-models-2026-04-29/ 2026-08-22T06:18:27+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-hana-securities-plant-utilization-recovery-%c2%b7-north-america-ess-demand-%c2%b7-valuation-re-rating-2026-04-29/ 2026-08-22T06:23:42+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-mirae-asset-securities-sdc-stake-monetization-pursuit-%c2%b7-north-america-ess-europe-ev-order-acceleration-%c2%b7-operating-profit-turnaround-2026-04-2/ 2026-08-22T06:28:53+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-ibk-securities-fully-booked-north-america-ess-%c2%b7-hungarian-utilization-recovery-%c2%b7-4q26-turnaround-2026-04-29/ 2026-08-22T06:30:38+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-im-securities-surging-aidc-ess-demand-%c2%b7-us-regulatory-tailwinds-%c2%b7-valuation-assessment-2026-04-29/ 2026-08-22T06:32:49+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-shinhan-securities-us-ess-demand-surges-%c2%b7-bbu-growth-%c2%b7-4q26-turnaround-2026-04-29/ 2026-08-22T06:34:33+00:00